These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9541583)

  • 1. Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses.
    Kim YJ; Kim SH; Mantel P; Kwon BS
    Eur J Immunol; 1998 Mar; 28(3):881-90. PubMed ID: 9541583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells.
    Chu NR; DeBenedette MA; Stiernholm BJ; Barber BH; Watts TH
    J Immunol; 1997 Apr; 158(7):3081-9. PubMed ID: 9120260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.
    Kim YJ; Brutkiewicz RR; Broxmeyer HE
    Blood; 2002 Nov; 100(9):3253-60. PubMed ID: 12384425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.
    Cannons JL; Choi Y; Watts TH
    J Immunol; 2000 Dec; 165(11):6193-204. PubMed ID: 11086053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
    Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
    J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
    Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
    J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
    Bertram EM; Lau P; Watts TH
    J Immunol; 2002 Apr; 168(8):3777-85. PubMed ID: 11937529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative abilities of 4-1BB (CD137) and CD28 to co-stimulate the response of cytokine deflected Th1 and Th2 cells.
    Vinay DS; Kwon BS
    Immunobiology; 1999 Jun; 200(2):246-63. PubMed ID: 10416132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses.
    Chan KW; Hopke CD; Krams SM; Martinez OM
    J Immunol; 2002 Aug; 169(4):1784-91. PubMed ID: 12165500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway.
    Melero I; Bach N; Hellström KE; Aruffo A; Mittler RS; Chen L
    Eur J Immunol; 1998 Mar; 28(3):1116-21. PubMed ID: 9541607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
    Finney HM; Akbar AN; Lawson AD
    J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-1BB costimulation promotes human T cell adhesion to fibronectin.
    Kim YJ; Mantel PL; June CH; Kim SH; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):13-23. PubMed ID: 10066342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
    Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
    J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.
    Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS
    J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
    Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
    Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4.
    Pollok KE; Kim SH; Kwon BS
    Eur J Immunol; 1995 Feb; 25(2):488-94. PubMed ID: 7875212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cells.
    Laderach D; Movassagh M; Johnson A; Mittler RS; Galy A
    Int Immunol; 2002 Oct; 14(10):1155-67. PubMed ID: 12356681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
    Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH
    J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.